63 related articles for article (PubMed ID: 7520643)
1. [Controlled, clinical trial of isoprinosine administration to HIV-infected patients. Results of a Danish/Swedish multicenter study. The Scandinavian Isoprinosine Study Group].
Thorsen S; Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO
Ugeskr Laeger; 1994 May; 156(22):3314-8. PubMed ID: 7520643
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
[TBL] [Abstract][Full Text] [Related]
3. [Promising results of a Danish-Swedish clinical trial: isoprinosine administered to HIV positive patients prevented development of AIDS].
Lennholm B
Lakartidningen; 1990 Jun; 87(26-27):2253. PubMed ID: 1694549
[No Abstract] [Full Text] [Related]
4. One-year follow-up on the safety and efficacy of isoprinosine for human immunodeficiency virus infection. Scandinavian Isoprinosine Study Group.
Thorsen S; Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO
J Intern Med; 1992 Jun; 231(6):607-15. PubMed ID: 1377741
[TBL] [Abstract][Full Text] [Related]
5. Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS.
Bekesi JG; Tsang PH; Wallace JI; Roboz JP
J Clin Lab Immunol; 1987 Dec; 24(4):155-61. PubMed ID: 2452254
[TBL] [Abstract][Full Text] [Related]
6. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
[TBL] [Abstract][Full Text] [Related]
7. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
9. Effect of isoprinosine on HIV antigenaemia.
Teglbjaerg LL; Kroon S; Sandström E; Moestrup T; Hansson BG; Vestergaard BF
AIDS; 1992 Feb; 6(2):199-201. PubMed ID: 1373064
[TBL] [Abstract][Full Text] [Related]
10. Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.
Izzedine H; Hulot JS; Vittecoq D; Gallant JE; Staszewski S; Launay-Vacher V; Cheng A; Deray G;
Nephrol Dial Transplant; 2005 Apr; 20(4):743-6. PubMed ID: 15741212
[TBL] [Abstract][Full Text] [Related]
11. [Isoprinosine treatment of herpes zoster. Résults of a control study in 36 subjects (author's transl)].
Lesourd B; Laude J; Meunier P; Doumerc S; Moulias R
Nouv Presse Med; 1982 Jan; 11(3):191-3. PubMed ID: 6173843
[TBL] [Abstract][Full Text] [Related]
12. Isoprinosine (inosine pranobex BAN, INPX) in the treatment of AIDS and other acquired immunodeficiencies of clinical importance.
Glasky AJ; Gordon JF
Cancer Detect Prev Suppl; 1987; 1():597-609. PubMed ID: 2446760
[TBL] [Abstract][Full Text] [Related]
13. [Isoprinosine therapy in chronic hepatitis C (multicenter placebo-controlled double-blind prospective study)].
Pár A; Beró T; Brasch G; Gógl A; Kamarás G; Méhesfalvi E; Ozsvár Z; Paál M; Szipöcs I; Telegdy L
Orv Hetil; 1993 May; 134(19):1015-9. PubMed ID: 7684118
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
15. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.
Hamza OJ; Matee MI; Brüggemann RJ; Moshi MJ; Simon EN; Mugusi F; Mikx FH; van der Lee HA; Verweij PE; van der Ven AJ
Clin Infect Dis; 2008 Nov; 47(10):1270-6. PubMed ID: 18840077
[TBL] [Abstract][Full Text] [Related]
16. AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
Gartland M;
Antivir Ther; 2001 Jun; 6(2):127-34. PubMed ID: 11491417
[TBL] [Abstract][Full Text] [Related]
17. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Sorge J; Sittl R
Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
[TBL] [Abstract][Full Text] [Related]
18. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
20. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]